Press Releases

Hogan Lovells is selected for Novartis Preferred Firm Program

Washington D.C.,13 February 2020 – Hogan Lovells is pleased to announce that it has been selected for the newly adopted Novartis Preferred Firm Panel 3.0. We have pledged to meet the...

Press Releases

Hogan Lovells advises MorphoSys on global licensing and development of blood cancer drug tafasitamab

Led by its partners Jörg Schickert and Arne Thiermann, and in close collaboration with MorphoSys in-house deal counsel Virginie Galitschke, international law firm Hogan Lovells has...

Press Releases

Hogan Lovells advises Vifor Pharma on establishment of joint venture with Evotec for early stage development in nephrology

Led by Munich partner Michael Rose, Hogan Lovells has advised the Swiss pharmaceutical company Vifor Pharma on the establishment of a joint venture with Evotec focusing on the research and...

Press Releases

Hogan Lovells represents Novartis in Collaboration and Exclusive Option Agreement with IFM Therapeutics

International law firm Hogan Lovells team advised Swiss pharmaceuticals company Novartis in a collaboration and option agreement with IFM Due, a subsidiary of Boston-based biopharmaceutical ...

Published Works

The controversy over gene-editing

Awards and Rankings

Hogan Lovells named LMG Life Science Regulatory Firm of the Year, Alice Valder Curran and Adam Golden named Regulatory and M&A Attorneys of the Year

Washington, D.C., 25 September 2018 – Hogan Lovells is pleased to announce that it scored three major wins at the sixth annual LMG Life Sciences Awards honoring top-ranking firms and...

Awards and Rankings

Hogan Lovells wins IP Team of the Year at 2018 The Lawyer Awards: The firm is also commended for its litigation, real estate and pro bono work

Hogan Lovells is delighted to announce that the firm has been named as Intellectual Property Team of the Year at the inaugural 2018 The Lawyer Awards.

Loading data